Astera Labs (NASDAQ:ALAB – Get Free Report) was upgraded by equities researchers at Northland Securities from a “market perform” rating to an “outperform” rating in a note issued to investors on Wednesday, Marketbeat.com reports. The firm presently has a $315.00 price target on the stock. Northland Securities‘s price target indicates a potential upside of 34.83% from the company’s current price.
Several other research firms also recently weighed in on ALAB. Susquehanna upped their price target on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Barclays lifted their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Jefferies Financial Group boosted their target price on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Morgan Stanley upped their target price on shares of Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Finally, Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Twelve analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $332.37.
Read Our Latest Analysis on Astera Labs
Astera Labs Stock Up 1.7%
Shares of Astera Labs stock opened at $233.62 on Wednesday. The company has a market capitalization of $40.53 billion, a price-to-earnings ratio of 115.65 and a beta of 3.85. The stock’s 50-day simple moving average is $306.13 and its 200-day simple moving average is $255.53. Astera Labs has a 52 week low of $97.89 and a 52 week high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. The firm had revenue of $584.90 million during the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm’s revenue was up 153.6% on a year-over-year basis. During the same quarter last year, the business posted $0.49 earnings per share. On average, equities analysts expect that Astera Labs will post 2.71 earnings per share for the current year.
Insider Buying and Selling at Astera Labs
In other news, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares in the company, valued at approximately $32,872,551. This represents a 6.58% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 408,558 shares of company stock worth $127,306,034. Company insiders own 10.40% of the company’s stock.
Hedge Funds Weigh In On Astera Labs
A number of institutional investors and hedge funds have recently made changes to their positions in ALAB. Keating Financial Advisory Services Inc. purchased a new stake in shares of Astera Labs during the 2nd quarter valued at about $25,000. GK Wealth Management LLC purchased a new position in Astera Labs in the third quarter worth about $29,000. Archer Investment Corp bought a new stake in Astera Labs during the second quarter worth approximately $30,000. Signature Equity Partners LLC increased its stake in Astera Labs by 1,680.0% during the third quarter. Signature Equity Partners LLC now owns 89 shares of the company’s stock worth $32,000 after acquiring an additional 84 shares during the last quarter. Finally, Whipplewood Advisors LLC increased its stake in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after acquiring an additional 319 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs reported record Q3 revenue of $584.9 million, up 49% quarter over quarter and 154% year over year. Adjusted earnings of $1.32 per share beat the $1.19 consensus estimate, as did revenue versus expectations of $550.78 million. Astera Labs Reports Third Quarter 2026 Financial Results
- Positive Sentiment: Growth was led by the Scorpio fabric-switch family, now Astera Labs’ largest product line, with volume production of the Scorpio X-Series 320-lane switch. The company also expanded products for memory, optical and copper connectivity, and rack-scale AI systems—supporting its opportunity in AI infrastructure. Q3 2026 Earnings Call Highlights
- Positive Sentiment: Reports said the company’s forward guidance also topped estimates, adding to the earnings beat and potentially reinforcing expectations for continued demand. Astera Labs Q3 Results and Guidance
- Negative Sentiment: The results arrive after a sharp retreat: a recent report said ALAB had fallen about 54% from its year-to-date high and broken below key support. That weakness may keep volatility elevated and leave investors focused on whether earnings growth can restore confidence. Astera Labs Stock and Key Support
Astera Labs Company Profile
Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.
Further Reading
- Five stocks we like better than Astera Labs
- Shopify’s Small Q3 Miss Triggered a Big Sell-Off: What’s Next?
- Can Oil’s Big Rally Deliver Reliable Income? 3 Energy Plays to Watch
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
